These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 33549035

  • 1. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K.
    BMC Infect Dis; 2021 Feb 06; 21(1):153. PubMed ID: 33549035
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
    Abdelmessih E, Patel N, Vekaria J, Crovetto B, SanFilippo S, Adams C, Brunetti L.
    Pharmacotherapy; 2022 Sep 06; 42(9):741-753. PubMed ID: 35869689
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Covvey JR, Erickson O, Fiumara D, Mazzei K, Moszczenski Z, Slipak K, Nemecek BD, Zimmerman DE, Guarascio AJ.
    Ann Pharmacother; 2020 Jul 06; 54(7):644-651. PubMed ID: 31888350
    [Abstract] [Full Text] [Related]

  • 4. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP.
    Pharmacotherapy; 2015 Oct 06; 35(10):889-98. PubMed ID: 26497475
    [Abstract] [Full Text] [Related]

  • 5. Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital.
    McClure S, McElroy L, Gugkaeva Z.
    Am J Health Syst Pharm; 2024 May 24; 81(11):e283-e288. PubMed ID: 38253056
    [Abstract] [Full Text] [Related]

  • 6. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, Desai J, Holubar M, Deresinski S.
    Pharmacotherapy; 2019 Apr 24; 39(4):433-442. PubMed ID: 30739349
    [Abstract] [Full Text] [Related]

  • 7. Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Chavada R, Ghosh N, Sandaradura I, Maley M, Van Hal SJ.
    Antimicrob Agents Chemother; 2017 May 24; 61(5):. PubMed ID: 28242672
    [Abstract] [Full Text] [Related]

  • 8. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.
    Int J Antimicrob Agents; 2015 Dec 24; 46(6):689-95. PubMed ID: 26555059
    [Abstract] [Full Text] [Related]

  • 9. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, Pogue JM, Rybak MJ.
    Antimicrob Agents Chemother; 2017 Dec 24; 61(12):. PubMed ID: 28923869
    [Abstract] [Full Text] [Related]

  • 10. The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
    Moriyama H, Tsutsuura M, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K.
    J Infect Chemother; 2021 May 24; 27(5):781-785. PubMed ID: 33563525
    [Abstract] [Full Text] [Related]

  • 11. Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Johnston MM, Huang V, Hall ST, Buckley MS, Bikin D, Barletta JF.
    Diagn Microbiol Infect Dis; 2021 Oct 24; 101(2):115442. PubMed ID: 34192639
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K, Ramireddy K, Madison G, Turco T, Lui M.
    J Clin Pharm Ther; 2021 Aug 24; 46(4):1103-1108. PubMed ID: 33768555
    [Abstract] [Full Text] [Related]

  • 13. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R, So H, Seo E, Kim M, Lee J.
    PLoS One; 2021 Aug 24; 16(4):e0247714. PubMed ID: 33793589
    [Abstract] [Full Text] [Related]

  • 14. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K, Jono H, Nosaka K, Saito H.
    Int J Antimicrob Agents; 2020 Oct 24; 56(4):106109. PubMed ID: 32721597
    [Abstract] [Full Text] [Related]

  • 15. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM, Seabury RW, Steele JM, Darko W, Miller CD.
    J Pharm Pract; 2017 Jun 24; 30(3):329-335. PubMed ID: 27074786
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Therapeutic Vancomycin Monitoring in Taiwan.
    Chen TT, Liu MP, Sun HC.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0156221. PubMed ID: 35412391
    [Abstract] [Full Text] [Related]

  • 17. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.
    Int J Antimicrob Agents; 2014 Feb 27; 43(2):179-83. PubMed ID: 24315788
    [Abstract] [Full Text] [Related]

  • 18. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K, Crumby AS, Maples HD.
    Paediatr Drugs; 2015 Apr 27; 17(2):97-103. PubMed ID: 25644329
    [Abstract] [Full Text] [Related]

  • 19. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
    Makmor-Bakry M, Ahmat A, Shamsuddin A, Lau CL, Ramli R.
    Anaesthesiol Intensive Ther; 2019 Apr 27; 51(3):218-223. PubMed ID: 31434472
    [Abstract] [Full Text] [Related]

  • 20. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
    Chen Q, Wan J, Shen W, Lin W, Lin X, Huang Z, Lin M, Chen Y.
    Pediatr Neonatol; 2022 May 27; 63(3):247-254. PubMed ID: 35190273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.